InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Kroll Werner, Vice-Président Senior, Recherche et Développement. Officer active across 2 companies, notably QUIDEL CORP. In total, 13 filings have been recorded. The latest transaction was filed on 27 May 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
04,376 shares0
Common Stock
SEC:0000899243-22-020398:0·
18,762 shares
Common Stock
SEC:0000899243-22-020510:0·
01,050 shares0
Common Stock
SEC:0001209191-22-009602:0·
04,268 shares0
Common Stock
SEC:0001209191-22-007862·
04,268 shares0
Common Stock
SEC:0001209191-22-007862:0·
01,312 shares0
Common Stock
SEC:0001209191-22-006637:0·
01,312 shares0
Common Stock
SEC:0001209191-22-006637·
04,606 shares0
Common Stock
SEC:0001209191-22-003880·
04,606 shares0
Common Stock
SEC:0001209191-22-003880:0·
0982 shares0
Common Stock
SEC:0001209191-21-045153·
0982 shares0
Common Stock
SEC:0001209191-21-045153:0·
04,376 shares0
Common Stock
SEC:0001209191-21-036977·
04,376 shares0
Common Stock
SEC:0001209191-21-036977:0·
13 of 13 declarations
About Kroll Werner
Werner Kroll is the Senior Vice President of Research & Development at Quidel Corp and QuidelOrtho Corp. He is responsible for research and development initiatives within these companies, which specialize in medical diagnostics. Kroll plays a crucial role in product innovation and improvement, contributing to the mission of providing quality health solutions. His expertise is vital for the success of research projects.
